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Candida albicans is the most common fungal pathogen of humans, forming both commensal and oppor-
tunistic pathogenic interactions, causing a variety of skin and soft tissue infections in healthy people. In
immunocompromised patients C. albicans can result in invasive, systemic infections that are associated
with a high incidence of mortality. Propolis is a complex mixture of several resinous substances which
are collected from plants by bees. Here, we demonstrated the fungicidal activity of propolis against all
three morphogenetic types of C. albicans and that propolis-induced cell death was mediated via metacas-
pase and Ras signaling. To identify genes that were involved in propolis tolerance, we screened 800 C.
albicans homozygous deletion mutants for decreased tolerance to propolis. Fifty-one mutant strains were
identiﬁed as being hypersensitive to propolis including seventeen genes involved in cell adhesion, bioﬁlm
formation, ﬁlamentous growth, phenotypic switching and pathogenesis (HST7, GIN4, VPS34, HOG1, ISW2,
SUV3, MDS3, HDA2, KAR3, YHB1, NUP85, CDC10, MNN9, ACE2, FKH2, and SNF5). We validated these results
by showing that propolis inhibited the transition from yeast-like to hyphal growth. Propolis was shown
to contain compounds that conferred ﬂuorescent properties to C. albicans cells. Moreover, we have shown
that a topical pharmaceutical preparation, based upon propolis, was able to control C. albicans infections
in a mouse model for vulvovaginal candidiasis. Our results strongly indicate that propolis could be used
as a strategy for controlling candidiasis.
 2013 Elsevier Inc. All rights reserved.1. Introduction
Candida albicans is a dimorphic fungus that normally resides as a
commenal organism within the gastrointestinal tract of humans
and other warm blooded animals. C. albicans is the most common
fungal pathogen of humans and is responsible for causing a variety
of skin and soft tissue infections in healthy people andmore virulent
systemic diseases in immunocompromised patients. The fact that C.
albicans can survive in healthy hosts and also cause a spectrum of
diseases in immunocompromised patients is a matter of signiﬁcant
biological interest, as well as clinical and economic importance (No-ble and Johnson, 2007). Candida spp. are present in approximately
50% of the population and around 80% of women have suffered from
Candida infections, with around 5% of these infections recurring
(Odds et al., 2004; Ramsdale, 2008). In immunocompromised indi-
viduals, C. albicans can produce mild superﬁcial infections of the
mouth and vagina. In severely immunocompromised patients, this
fungus can produce a disseminated, systemic infection that is asso-
ciated with a high incidence of mortality (Odds et al., 2004). C. albi-
cans is the fourth most common hospital infection and the rate of
resistance to traditional antifungal therapies is high (Yano and Fidel,
2011; Shapiro et al., 2011; Krcmery, 2000; Lamagni et al., 2001;
Ramsdale, 2008).
The striking feature of the morphology of C. albicans is its ability
to proliferate and switch rapidly from budding yeast-like, to
pseudohyphal or hyphal growth (Sudbery, 2011; Sudbery et al.,
2004; Odds et al., 1998; Whiteway and Bachewich, 2007). The
morphological plasticity of C. albicans is a virulence determinant
and plays a fundamental role in the infection process. During
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causing damage, probably through the release of hydrolytic en-
zymes (Zhu and Filler, 2010). C. albicans is perfectly adapted to
growth in its human host and forms hyphae under a variety of
environmental conditions that reﬂect the diversity of microenvi-
ronments that C. albicans encounters within the host (Sudbery,
2011). Hyphae are formed in response to the presence of serum,
neutral pH, 5% CO2 (the partial pressure of CO2 in the blood) and
N-acetyl-D-glucosamine (GlcNAc) (Mardon et al., 1969; Sudbery,
2011).
The diploid genome of C. albicans is approximately 30 Mb and
contains 8 pairs of homologous chromosomes (Jones et al., 2004;
van het Hoog et al., 2007). Signal transduction pathways and tran-
scription factors involved in the induction of hyphal growth have
been recently reviewed in detail by Shapiro et al. (2011). The
expression of hyphal growth-speciﬁc genes is negatively regulated
by a complex consisting of the Tup1 co-repressor and NRG1 or the
ﬁlamentous growth regulator type Rox1p (Rfg1). Cells lacking any
of these repressors constitutively grow as long pseudohyphae, as
the expression of hyphal-speciﬁc genes is not inhibited (Kadosh
and Johnson, 2005; Murad et al., 2001; Sudbery, 2011). The up-reg-
ulation of the expression of hyphal-speciﬁc genes is accomplished
by several transcription factors, including Efg1, Chp1, Cph2, Tec1,
Flo8, Czf1, Rim101 and Ndt80 (Shapiro et al., 2011; Sudbery,
2011; Stoldt et al., 1997; Lane et al., 2001; Cao et al., 2006; Davis
et al., 2000; Sellam et al., 2010). Efg1 is necessary for the formation
of hyphae in response to serum, neutral pH, CO2 and GlcNAc in li-
quid media and on solid spider media. Cph1 and its upstream acti-
vation pathway are needed only for forming hyphae on solid spider
media, but not in liquid media. Consequently, it was suggested that
Efg1 was the main regulator of the formation of hyphae under
most conditions. Cph1 and Efg1 are activated by upstream signal-
ing pathways such as the MAPK and cyclic AMP pathways (cAMP),
respectively (Shapiro et al., 2011; Biswas et al., 2007). The Ras1
GTPase regulates both the cAMP and MAPK pathways (Shapiro
et al., 2011; Sudbery, 2011; Stoldt et al., 1997; Leberer et al., 2001).
Propolis is a complex mixture of several resinous substances,
which are collected from plants by bees. Propolis has been used
in folk medicine for centuries. Its chemical composition complex,
since more than 300 compounds including polyphenols, phenolic
aldehydes, sequiterpene quinines, coumarins, amino acids, ste-
roids, and inorganic compounds, have been identiﬁed in different
propolis samples (Lustosa et al., 2008; Pereira et al., 2002; Franco
et al., 2000). Propolis has attracted attention because of the variety
of biological and therapeutic properties displayed. Propolis has
antibacterial (Koru et al., 2007; Park et al., 2002), antiviral (Vyno-
grad et al., 2000), antiprotozoal (Menna-Barreto et al., 2009),
anti-inﬂammatory (Ramos and Miranda, 2007), antioxidant (Si-
mões et al., 2004; Russo et al., 2002), wound healing (Berretta
et al., 2012), immunomodulatory (Sforcin, 2007), and anti-tumor
properties (Kimoto et al., 1998). Several authors have also shown
that propolis can be used to treat Candida infections (Aguero
et al., 2010; Dalken-Dota et al., 2010; Ota et al., 2001; Salomão
et al., 2008; Siqueira et al., 2009). Recently, we utilized Saccharo-
myces cerevisiae as a model organism plus genetics, cell biology,
and transcriptomic to determine how propolis affects eukaryotic
cells. We found that propolis was able to induce the apoptosis cell
death response, while increased exposure to propolis caused a
necrosis response. More speciﬁcally, we found that the most prom-
inent pathways were related to oxidative stress, the mitochondrial
electron transport chain, vacuolar acidiﬁcation, the regulation of
macroautophagy associated with protein targeting to the vacuole,
cellular response to starvation, and the negative regulation of tran-
scription from RNA polymerase II promoter (de Castro et al., 2011).
In the present study, we evaluated the antifungal activity of
propolis on C. albicans. We investigated speciﬁcally if propoliscould activate signaling and metabolic pathways related to cell
death. In addition, we determined the inﬂuence of propolis on
the growth of a collection of C. albicans deletion mutants aiming
to discover tolerance mechanisms that were impacted by propolis.
Propolis demonstrated fungicidal action against all three C. albicans
morphogenetic types and propolis-induced cell death was shown
to be mediated via metacaspase and Ras signaling. Interestingly,
we have identiﬁed several mutants that correspond to genes in-
volved in either morphological transition or in the maintenance
of a speciﬁc morphotype. We validated these results by showing
that propolis can inhibit the transition to hyphal growth. More-
over, we have shown that a medicine based upon propolis was able
to control a C. albicans infection in a mouse model of vulvovaginal
candidiasis. Our results strongly indicate that propolis represents a
promising strategy for controlling candidiasis.2. Materials and methods
2.1. Strains, media and culture methods
The C. albicans strains used were: SC5314 (Gillum et al., 1984),
CAI4 (ura3::imm434/ura3::imm434 iro1/iro1::imm434) (Fonzi and
Irwin, 1993), BWP17 (ura3::imm434/ura3::imm434 iro1/ir-
o1::imm434 his1::hisG/his1::hisG arg4/arg4) (Wilson et al.,
1999), DAY286 (ura3::kimm434 his1::hisG pARG4::URA3::ar-
g4::hisG, ura3::kimm434 his1::hisG arg4::hisG) (Davis et al.,
2002), 3153A, and 529L (wild type). Solid and liquid complete
YPD media (2% w/v glucose, 1% w/v yeast extract and 2% w/v
peptone), which only differed in the addition of agar (2% w/v),
were used for strain cultivation. Since propolis was dissolved in
ethanol (60% alcoholic extract), control treatment was vehicle
control (5.45% ethanol).
2.2. Propolis standardized extract
Propolis Standardized Extract (EPP-AF) (Batch 010/08) was
industrially produced and kindly provided by Apis Flora (Ribeirão
Preto, São Paulo, Brazil). The extract was standardized using a
blend of propolis composed of raw material obtained from several
sites in Brazil (Patent number PI 0405483-0, published in Revista
de Propriedade Industrial n. 1778 from 01/02/2005).
The blend of raw propolis was frozen for 12 h at 20 C and
then ground to a ﬁne powder using a blender. Propolis was then
extracted from the raw material using a hydro alcoholic solution
(7:3), with dynamic maceration, for 72 h at room temperature, fol-
lowed by percolation (1 l/min), and ﬁnally a ﬁltration process that
ﬁrst used the propolis biomass as a ﬁlter and then a 220 mesh
stainless steel industrial ﬁlter. The propolis extract obtained pre-
sents 11% w/v of the dry matter and the chemical composition
was evaluated by RP-HPLC (Shimadzu – C18 Shim-pack, CLC-ODS
(M), 25 cm  4.6 column, with gradient elution, with methanol
and acidic water pH 2.7, plotted at 275 nm) into compounds: caf-
feic acid (Fluka, L. 43706045), p-coumaric acid (Fluka,
L.3250759), trans-cinnamic acid (Fluka, L.21907066); the ﬂavonoid
aromadendrin-4’O-metil ether (previously isolated, identiﬁed and
donated by Sousa et al. (2007) and prenylated derivative and mar-
ker of green propolis, Artepillin C (Wako, L. 016.19131), according
to Berretta et al. (2012).
2.3. Medicines
To evaluate propolis efﬁcacy in vivo, topical pharmaceutical
preparations were developed based upon the propolis alcoholic ex-
tract (EPP-AF), however after the complete evaporation of the
alcohol and the resolubilization of propolis in propylene glycol.
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copolymer. Initially, poloxame (Lutrol F127) was dispersed in
water and maintained under hydration for 24 h at 5 C. Meanwhile,
Carbopol was dispersed in water solution containing 0.1% potas-
sium sorbate and 0.01% EDTA 0.01% and maintained under hydra-
tion for 24 h (Phase B). Then, under stirring, the mixture of propolis
(2% and 3%, for G2 and G3%, respectively), Melaleuca (Melaleuca
alternifolia), sweet birch (Betula lenta), Mentha spicata and rose-
mary (Rosmarinus ofﬁcinalis) essential oils and propylene glycol
were added gradually into the poloxamer dispersion (Phase A).
Afterwards, Carbopol 940 dispersion was mixed with phase A. Un-
der stirring, triethanolamine was used to adjust to pH 6 and also to
conferred viscosity to the preparation. To prepare an emulsion
(E3%), propolis (3%) was dispersed in etoxilated castor oil 40OE
and castor oil (Phase A) and potassium sorbate (0.1%) and EDTA
(0.01%) were dispersed in puriﬁed water (Phase B). Both phases
were warmed to around 60 C under agitation until both phases
reached a homogeneous temperature. Subsequently, phase B was
inverted into phase A, under agitation. When the temperature of
preparation was above 40 C, Melaleuca (Melaleuca alternifolia),
sweet birch (Betula lenta), Mentha spicata and rosemary (Rosmari-
nus ofﬁcinalis) essential oils and propylene glycol were added grad-
ually into the emulsion (cream). To all preparations, gels (G2 and
G3) and cream (E3), the respective controls were prepared without
propolis and essential oils. A conventional medicine for vaginal
candidiasis treatment, Clotrimazole cream (10 mg/g), was obtained
from Neo Química, Brazil, lot: LB12F1021.
2.4. Screening of the C. albicans deletion libraries
A set of approximately 800 C. albicans deletion mutants were
screened for increased sensitivity to propolis. Fifteen deletion li-
braries in 96 well plates were provided by Dr. Kevin McCluskey
of Fungal Genetics Stock Center (www.fgsc.net). To identify the
propolis-sensitive mutants, aliquots of the cultures, from fresh
96-well plates, were spotted on YPD plates plus 5.45% ethanol as
a control corresponding to the concentration of alcohol present
in the 1% of alcoholic extract, or alcoholic propolis extract (Apis
Flora, Ribeirão Preto, São Paulo, Brazil) at 0.5% or 1.0%. Plates were
incubated at 30 C for 5 days. Propolis sensitivity was determined
by a reduction in growth.
2.5. Viability determination
C. albicans strains were incubated in YPD liquid media
(150 rpm) at 30 C for 3, 6, 9 and 16 h. After this period, 1  107 -
cells/ml from each time point were inoculated into 50 ml of YPD li-
quid and exposed to different concentrations of propolis (0.125%,
0.250%, 0.5%, 1.0%) for 20 min. For the negative control, 5.45% eth-
anol was added to the medium. Cell viability was determined by
plating appropriate concentrations of cells and counting the num-
ber of colonies compared to the negative control, which had 100%
survival at all stages of the growth curve.
2.6. Evaluation of the sensitivity of C. albicans morphogenetic types to
propolis
In order to evaluate the sensitivity of C. albicans morphogenetic
types to propolis, the SC5314 strain was incubated in YPD liquid
media for 16 h in a shaking incubator at 30 C. After this period,
cells were counted and 2  107 cells/ml inoculated into fresh liquid
YPD media and return to the incubator for a further 4 h, at 30 C (to
maintain the yeast form), at 37 C (to induce pseudohyphae), and
in liquid YPD plus Fetal Bovine Serum (FBS) (20%) at 37 C (for
the formation of hyphae). Subsequently, 5.45% ethanol was added
for the negative control, while for the 1% propolis treatment,20 min and 1 h incubations were used. In order to verify the effec-
tiveness of the transition, an aliquot of each culture was taken and
observed on a Carl Zeiss microscope. After treatment, a tenfold se-
rial dilution of the cells was plated on solid YPD media.
2.7. Dimorphic transition and Mitotracker microscopy
To analyse the effect of the propolis alcoholic extract on C. albi-
cans ﬁlamentation, the SC5314 strain was grown for 16 h in liquid
YPD media within a shaking incubator at 30 C. The yeast cells
were harvested by centrifugation, washed three times in ﬁlter ster-
ilized ultra-pure water and counted using a haemocytometer.
Approximately, 2  107 cells/ml were added to 1 ml of RPMI1640
media (to induce ﬁlamentation) containing 0.05; 0.1% or 0.2% prop-
olis. The RPMI1640 medium without propolis was used as a nega-
tive control. The samples were then incubated for 90 min at 37 C
under shaking (100 rpm). Afterwards, the cells were collected by
centrifugation (5 min at 4000 rpm) and washed with phosphate
buffered saline (PBS). Before ﬁxation, cell viability was determined
by plating serial dilutions of the cells on YPD agar plates. Under
those concentrations, the propolis extract was not toxic to the fun-
gal cell (data not show). Subsequently, the cells were ﬁxed with
3.7% l formaldehyde (J.T. Baker) in PBS for 15 min at room temper-
ature. After ﬁxation, the cells were washed once with PBS. To stain
the mitochondria, the cells were incubated with 250 nM Mitotrac-
ker (Invitrogen) diluted in PBS for 10 min at room temperature
and washed once with PBS. To stain the nuclei, the cells were incu-
bated with 250 ng DAPI (Invitrogen) in a PBS solution containing
42.5% glycerol for 10 min at room temperature and washed once
with PBS. Finally, the stained cells were washed with PBS, mounted
and viewed on a Carl Zeiss Observer Z1 ﬂuorescence microscope
(Jena, Germany) using the following ﬁlters: ﬁlter set 38 HE (wave-
length excitation 470/40 nm and emission wavelength, 525/
50 nm) for GFP; ﬁlter Set 49 (wavelength excitation 365 nm and
emission wavelength 445/50 nm) for DAPI and ﬁlter set 63 HE
(wavelength excitation 572/25 nm and emission wavelength 629/
62 nm) for Mitotracker. To quantify C. albicans ﬁlamentous forms,
at least 100 cells per sample were assessed and the ﬁlamentation
percentage calculated. The experiment was repeated three times.
For ﬂuorescence analysis, mitochondria were stained in red (Mito-
tracker), nuclei in blue (DAPI) and the propolis alcoholic extract
(autoﬂuorescent) gave a signal under the GFP ﬁlter.
2.8. Murine model of vulvovaginal candidiasis and C. albicans bioﬁlm
formation
This protocol was performed as described by Yano and Fidel
(2011) with some modiﬁcations. Brieﬂy, female mice (BALB/c
strain, at 7–8 weeks of age with a body weight of 20 to 22 g,) were
housed in vented cages containing 5 animals. Three days before
infection, mice were treated with b-estradiol (17 b-estradiol valer-
ate) at 0.3 mg dissolved in 100 ll of castor oil (Sigma) and admin-
istered subcutaneously into the back of each animal, three days
before infection. The estrogen injection was repeated weekly
throughout the period of the study. To prepare cells for the infection
study, the C. albicans 3153A strain was incubated on YPD agar
plates at 30 C for 48 h. An isolated colony was inoculated in liquid
YPD medium and grown for 16 h in a shaking incubator at 30 C.
Cell cultures were spun for 5 min at 3000g, washed twice with
PBS, counted using a haemocytometer, and diluted at a concentra-
tion of 2.5  106 cell/ml. Twenty ll of this inoculum was inocu-
lated by inserting the pipette tip about 5 mm deep into the
vaginal lumen.
The animals were divided into ﬁve groups (n = 10): (i) control
(animals infected without treatment (gel without propolis), (ii)
treated with gel containing 2% of propolis dry matter, (iii) gel
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of propolis dry matter and ﬁnally (v) clotrimazole (Clotrimazol
vaginal cream 10 mg/g, Neo Química, Brazil, lot: LB12F1021).
The treatments were carried out for 10 days, and approximately
every 12 h 60 ll of the product was applied, ﬁlling the vaginal cav-
ity completely. In order to verify the cell morphology, an aliquot of
10 ll of the lavage was observed on a Carl Zeiss microscope.
The quantiﬁcation of vaginal fungal burden was performed by
inoculating a dilution of the lavage onto solid YPD media, in order
to obtain about 100 colonies per plate. Counting of the colonies
forming units (CFUs) was performed after incubation at 30 C for
24 h. The animals were evaluated for 10 days post treatment and
re-evaluated daily through the culture of the intravaginal lavages.
The analysis of variance (ANOVA – one way) and the Bonferroni
multiple comparison were performed with a 5% level of signiﬁ-
cance. Statistical analyses were performed using Prism 4 (Graph
Pad).
The histopathology study was carried out following the vaginal
lavage procedure and after the sacriﬁce. The vaginal tissue of 2
mice from each group were removed and ﬁxed for 24 h in 3.7%
formaldehyde–PBS. Samples were washed several times in 70%
alcohol before dehydration in a series of alcohol solutions of
increasing concentrations. Finally, the samples were diafanized in
xylol and embedded in parafﬁn. For each sample, sequential 5-
lm-thick sections were collected on glass slides and stained with
Gomori methenamine silver (GMS) or hematoxylin and eosin
(HE) stain. Brieﬂy, sections were deparafﬁnized, oxidized with 4%
chromic acid, stained with methenamine silver solution, and coun-
terstained with picric acid. For HE staining, sections were deparaff-
inized and stained ﬁrst with hematoxylin and then with eosin. All
stained slides were immediately washed, preserved with mounting
medium and sealed with a coverslip. Microscopic analyses were
done using an Axioplan 2 imaging microscope (Zeiss) at the stated
magniﬁcations under bright-ﬁeld light.
C. albicans bioﬁlms were formed in the wells of commercially
available presterilized, polystyrene, ﬂat-bottomed, 96-well micro-
titer plates as described previously by Pierce et al. (2008) and
Rukayadi et al. (2011). The antimicrobial activity of propolis on C.
albicans bioﬁlms was monitored using the XTT [2,3 - bisFig. 1. Propolis induces cell death in C. albicans. (A) Spot dilution assays for different
propolis. The plates were incubated at 30 C for 72 h. (B) Viability of C. albicans cells in d
viability was determined by plating appropriate cell concentrations and counting the nu
independent experiments.(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxani-
lide] reduction assay (Pierce et al., 2008). Antimicrobial activities
for each isolates were expressed by the mean optical density (±
standard deviation) at 490 nm wavelength (OD490).
3. Results
3.1. Propolis induces cell death in C. albicans
The tolerance of three C. albicans strains SC5314, 3153A and
529L, of which the last two are considered hypervirulent in the
mouse model of vulvovaginal candidiasis (Yano and Fidel, 2011;
Rahman et al., 2007) to propolis was assessed. All three C. albicans
strains could not grow in the presence of 1.0% propolis (Fig. 1A).
We also investigated the viability of the C. albicans cells at different
stages of the growth curve. For this, we concentrated our attention
on the SC5314 strain. Cells in the stationary phase (16 h) were
more resistant to the propolis extract when compared to other
stages of the growth curve (Fig. 1B). Similar results were observed
for the strains 3153A and 529L (data not shown). However, the
3153A strain was more tolerant to propolis than the 529L and
SC5314 strains (Fig. 1A).
3.2. Propolis inhibits all three C. albicans morphogenetic types
We evaluated the tolerance of the different morphogenetic
types of C. albicans to propolis. The transition from yeast-like to hy-
phal growth was about 95%, whereas from yeast-like to pseudohy-
phal growth was about 60% (Fig. 2A). The three different
morphogenetic types were incubated with 1% propolis (or 5.45%
ethanol for the negative control) for 20 min or 1 h, under the
appropriate conditions to maintain the respective morphogenetic
type. A tenfold serial dilution of the cells was plated onto solid
YPD. The growth of all morphogenetic types was equally inhibited
by propolis at 20 min and 1 h (Fig. 2B). Similar results were ob-
served for the strains 3153A and 529L (data not shown). Taken to-
gether, these results suggest that the alcoholic extracts of propolis,
used at a concentration of 1% was able to completely inhibit the
growth of all the different C. albicans morphogenetic types.C. albicans strains in YPD medium supplemented with different concentrations of
ifferent growth phases exposed to 0.125%, 0.250%, 0.500% and 1.0% for 20 min. Cell
mber of colonies. The numbers presented are average ± standard deviation of three
Fig. 2. C. albicans morphogenetic types showed equal tolerance to propolis. After induction of pseudohyphae and hyphae forms (A), cells were treated with 1% propolis for
20 min and 1 h. (B) Tenfold serial dilution were made and dripped onto plates containing YPD solid. The plates were incubated at 30 C for 72 h. In order to verify the
efﬁciency of the transition, a aliquot was withdrawn and checked via microscopy. Bars 5 m.
78 P.A. de Castro et al. / Fungal Genetics and Biology 60 (2013) 74–863.3. The involvement of metacaspases and the Ras signaling in C.
albicans propolis-induced cell death
Caspases are cysteine proteases that are involved in cell death
in eukaryotes (Li and Yuan, 2008). We have previously shown that
the S. cerevisiae YCA1 gene (a type I metacaspase) is important for
propolis-mediated cell death (de Castro et al., 2011). Interestingly,
deletion of the YCA1 functional homologue in C. albicans, IPF4847
(orf19.5995), results in increased resistance to oxidative stress,
suggesting that in C. albicans this gene encodes a metacaspase
responsible for programmed cell death (PCD) induced by oxidative
stress (Cao et al., 2009; Aerts et al., 2009). Thus, we determined the
viability of C. albicans strains BWP17 (wild-type) and mca1D/D
(Aerts et al., 2009) after treatment with propolis. When the wild-
type strain was exposed to 1% propolis for 10 or 20 min, there
was a 70% and 94% reduction in cell viability, respectively. In the
metacaspase mutant, this reduction was about 46% and 90%
(Fig. 3A). These results indicate that C. albicans MCA1 gene was
important for cell death mediated by propolis.
According to Phillips et al. (2006), the apoptotic response in C.
albicans can be triggered by exposure to H2O2, intracellular acidiﬁ-
cation, or a low dose of the antifungal agent amphotericin B. How-
ever, the mechanisms by which C. albicans undergoes apoptosis are
still unclear. The Ras pathway appears to be involved in apoptotic
signaling induced by acetic acid and hydrogen peroxide (Phillips
et al., 2006). The artiﬁcial activation of Ras accelerates the rate at
which the cells become apoptotic, but the activation of Ras alone
is not sufﬁcient to kill cells. Mutants that have Ras-cAMP-PKA sig-
naling blocked (ras1D, cdc35D, tpk1D, and tpk2D) suppress or de-
lay the apoptotic response, whereas mutations that stimulate
signaling such as RASval13 and pde2D show an accelerated rate of
entry into apoptosis (Phillips et al., 2006). Thus, we decided to
evaluate if these genes were involved in the cell death induced
by propolis, by investigating their tolerance to propolis (Fig. 3B).
The mutants cdc35D and ras1D, which block Ras signaling, showed
increased viability upon incubation with propolis (Fig. 3B). In con-
trast, the tpk1D, tpk2D, and pde2D mutants showed greater sensi-tivity to propolis (Fig. 3B). Taken together, these results imply that
cell death induced by propolis was mediated via metacaspase and
Ras signaling.
3.4. Identiﬁcation of other C. albicans genes involved in propolis-
induced cell death
To identify genes that were involved in the tolerance of propo-
lis, we screened the following C. albicans deletion libraries: (i) tran-
scription factor (TF), (ii) cell wall protein (CW), (iii) kinase (K) and
(iv) miscellaneous (M) homozygous mutants (available at the Fun-
gal Genetics Stock Center). Approximately 800 different mutants
were involved in this screening. These mutant libraries were
grown either on plates containing 5.45% ethanol (as control) or
0.5% and 1% of alcoholic extract of propolis for 5 days at 30 C.
Fifty-one mutant strains were identiﬁed as being hypersensitive
to propolis when compared with the corresponding wild-type
strains (Table 1; Supplementary Table S1 and Fig. S1). The analysis
of these mutants through the Candida Genome Database (http://
www.candidagenome.org) allowed the identiﬁcation of the possi-
ble biological processes of each gene, as well as the orthologues
in S. cerevisiae (Supplementary Table S1). Furthermore, we have
analyzed our data based upon the recently improved annotation
of gene ontologies involved in bioﬁlm formation, ﬁlamentous
growth, and phenotytic switching in C. albicans (Inglis et al., 2013).
Protein kinases, phosphatases and transcription factors play
important roles in signaling and response to changes in the exter-
nal environment. The ability of C. albicans to rapidly detect and re-
spond to changes in the environment is critical to its survival in the
human host (Blankenship et al., 2010). We observed 11 protein ki-
nases, 4 transcription factors and 2 tyrosine phosphatases from a
total of 167 mutants as being more sensitive to propolis (Table 1
and Supplementary Table S1). The 11 protein kinases were catego-
rized in terms of function and evolution (http://kinome.com) into
the major groups of protein kinases: STE (HST7, CDC15); CaMK
(GIN4), AGC (RIM15) and CMGC (HOG1), Atypical/PIKK/ATM
(VPS34), Atypical/HisK (KIS1), Other/Dicty10 (CTK3) and MSS2,
Fig. 3. The C. albicansmetacaspase, cdc35D and ras1Dmutants are more tolerant to
propolis. (A) The viability of the C. albicans cells for wild-type and metacaspase
mutant strains grown for 16 h and exposed to 1% propolis was determined by
plating of appropriate concentrations of cells and then counting the number of
colonies. The results are related to the mean ± standard deviation of three
independent experiments. Statistical analysis was performed by the one-way
ANOVA with Newman Keuls post test (p < 0.05). (B) The viability of the C. albicans
wild-type, cdc35D and ras1D mutant strains grown for 16 h and exposed to 1%
propolis was determined by plating appropriate concentrations of cells and then
counting the number of colonies. The results are related to the mean ± standard
deviation of three independent experiments. Statistical analysis was performed by
Dunnett’s multiple comparisons test (p < 0.05).
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nal.com/reference/kinase; Table 1 and Supplementary Table S1).
Interestingly, nine of these mutants (VPS34, HOG1, SUV3, MDS3,
PTP3, YHB1, CDC10, ACE2, and FKH2) sensitive to propolis showed
attenuated or an absence of virulence in different mouse models
(Supplementary Table S1). Two of the four identiﬁed transcription
factors, ACE2 and FKH2, also have reduced virulence in the mouse
model, while only the PPT3 tyrosine phosphatase mutant has re-
duced virulence in an insect model (Table 1 and Supplementary
Table S1).
The miscellaneous gene functions identiﬁed included chroma-
tin remodeling (ISW2 and HDA2), iron transport (FTH1), protein
degradation (DOA4 and HSM3), lipid degradation (LIP6), mating
(HST7, KAR3), mouse virulence (VPS34, HST7, MDS3, ACE2, YHB1,
CDC10), chlamydospore formation and morphology (SUV3, ISW2,
MDS3, CDC10), cytokinesis (GIN4), septin ring formation inside
the germ tube (GIN4, CDC10), caspofungin-, ﬂuconazole-, and
hydrogen peroxide-sensitivity (HST7, CKB1, CKB2, VPS34, KIS1,
GZF3, FTH1, SSN8), vesicular transport (VPS34), the transport of
Golgi apparatus to the vacuole (APL3), bioﬁlm formation (HIT1,
ACE2, MDS3, CaO19.12732), response to stress (HOG1), mitochon-
drial RNA catabolism (SUV3), macrophage interaction (YHB1), an
age-dependent response to oxidative stress involved in chronolog-
ical cell aging (RIM5) and ﬁbroblast adherence (VPS34).
Actually, 16 of these mutants correspond to genes that have
been annotated to the biological processes of cell adhesion,
bioﬁlm formation, ﬁlamentous growth, phenotypic switching andpathogenesis (Inglis et al., 2013), HST7, GIN4, VPS34, HOG1, ISW2,
SUV3, MDS3, HDA2, KAR3, YHB1, NUP85, CDC10, MNN9, ACE2,
FKH2, and SNF5 (Table 1 and Supplementary Table S1). Six of these
mutants correspond to genes that have orthologues predicted to
play a role in the virulence of other Candida species or strains,
but not only in the C. albicans SC5314 strain (Inglis et al., 2013):
VPS34, HOG1, MDS3, YHB1, CDC10, and ACE2 (Table 1 and Supple-
mentary Table S1).3.5. Propolis inhibits the dimorphic transition from yeast to hyphal
growth in C. albicans
In total, 12 of the 51 genes identiﬁed were involved in the mor-
phological transitions or in the maintenance of a speciﬁc morpho-
type (Table 1 and Supplementary Table S1; http://www.candidage
nome.org/): (i) hyphal growth and formation (HST7, VPS34, PTP3,
MNN9, SUV3, andMDS3), (ii) hyperﬁlamentation (ACE2), (iii) hyphal
morphology (CDC10), (iv) hyphal-speciﬁc gene transcription
(FKH2), (v) hyphal downregulation (YHB1), (vi) pseudohyphal
growth (PTP1) and (vi) required for pseudohyphal to hyphal transi-
tion (GIN4). Thus, we decided to evaluate the effect of propolis on
the dimorphic transition from yeast to hyphal growth (Fig. 4). The
C. albicans SC5314 strain was transferred to RPMI1640 media, to
induce ﬁlamentation, in the presence of 0.05, with or without the
addition of 0.05%, 0.1% and 0.2% propolis (with the corresponding
ethanol concentration as control). These concentrations were not
fungicidal. Post exposure to propolis, cell viability was checked
and there was no signiﬁcant induction of cell death at the used
concentrations (Fig. 4A). In contrast, there was a dramatic reduc-
tion in the transition to ﬁlamentation of approximately 30% and
90%, respectively, when the cells were grown in the presence of
0.1% and 0.2% propolis (Fig. 4B).
During these tests, we have noticed that when C. albicans yeast,
pseudohyphal or hyphal forms were exposed to alcoholic extracts
of propolis for at least 10 min emitted a green ﬂuorescence. This
ﬂuorescence was distributed along the cell and also grouped on
structures that are similar to the mitochondrial shape (Fig. 5).
These structures were conﬁrmed as mitochondria by co-staining
with Mitotracker (Fig. 5). These results indicate that propolis can
inhibit the yeast to hyphal transitions and it has compounds that
confer ﬂuorescent properties to C. albicans cells, accumulating into
the mitochondria.3.6. Propolis can reduce C. albicans burden in a vulvovaginal
candidiasis mouse model
To evaluate if propolis can inhibit C. albicans infection, we
established a vulvovaginal candidiasis mouse model with the
hypervirulent strain 3153A (Yano and Fidel, 2011). We prepared
three different propolis formulations (G2 and G3 poloxamer based
gels, and ﬁnally, E3 emulsion gelled with carbopol, containing 2%,
3%, and 3% propolis dry matter respectively) and treated cohorts
of 10 infected animals by applying intravaginally 60 ll of each for-
mulation every 12 h for 10 days. We evaluated fungal burden after
10 days of propolis applications and also after 10 days following
interruption of the treatments (Fig. 6). As a positive control, ani-
mals were treated with clotrimazole cream (10 mg/g). After
10 days of propolis treatment there was a 83.5%, 87.7%, 95.4%,
and 97.9% reduction in fungal burden for G2, G3, E3 and clotrima-
zole, respectively, when compared to the control group (Fig. 6A).
After 10 days with treatment interruption, there was a 90.1%,
87.7%, 84.7% and 68.4% reduction in fungal burden for G2, G3, E3
and clotrimazole, respectively, when compared to the control
group (Fig. 6B). All the treatments were different from the control
but statistically similar to the clotrimazole treatment (p < 0.05).
Table 1
Selected C. albicans mutant strains that showed increased susceptibility to propolis.
Sensitivity* Gene S. cerevisae
Orthologue
Function
Kinase
– HST7 STE7 MAP kinase
– CTK3 CTK3 Cyclin-dependent protein kinase
– GIN4 GIN4 Autophosphorylated kinase; role in pseudohyphal–hyphal switch and cytokinesis
+/ MSS2 MSS2 Role in protein insertion into mitochondrial membrane from inner side
+/ CDC15 CDC15 Protein serine/threonine kinase activity, ATP binding activity and role in protein phosphorylation
+/ RIM15 RIM15 Protein kinase activity, role in age-dependent response to oxidative stress
+/ CKB2 CKB2 Regulatory subunit of protein kinase CK2
– CKB1 CKB1 Regulatory subunit of protein kinase CK2
+/ VPS34 VPS34 Autophosphorylated class III phosphatidylinositol 3-kinase
+/ HOG1 HOG1 MAP kinase of osmotic-, heavy metal-, and core stress response
+/ KIS1 GAL83 Snf1p complex scaffold protein
Miscellaneous
+/ CRD1 CRD1 Protein similar to S. cerevisiae Crd1p, a cardiolipin synthase
+/ ISW2 ISW2 Protein required for chlamydospore formation; similar to S. cerevisiae Isw2p, an ATPase involved in chromatin
remodeling
– HDA2 HDA2 Histone deacetylase activity
+/ SUV3 SUV3 Similar to S. cerevisiae Suv3p, which is an RNA helicase involved in mitochondrial RNA catabolism
– MDS3 MDS3 TOR signaling pathway component required for growth and hyphal formation
– MUB1 MUB1 Protein monoubiquitination; have role in regulation of cell budding,
– HIT1 HIT1 Bioﬁlm-induced gene
– KAR3 KAR3 Kinesin-like microtubule motor protein
– BUR2 BUR2p Protein with similarity to S. cerevisiae Bur2p, contains a cyclin domain
– PEX14 PEX14 Protein binding, bridging activity, role in protein import into peroxisome matrix
– FTH1 FTH1 Protein similar to S. cerevisiae Fth1p, a high afﬁnity iron transporter for intravacuolar stores of iron
+/ HSM3 HSM3 Ortholog(s) have role in proteasome regulatory particle assembly, mismatch repair and nucleus, cytosol, proteasome
regulatory particle, base subcomplex localization
+/ UGA2 UGA2 Protein not essential for viability; similar to S. cerevisiae Uga2p, which is succinate semialdehyde dehydrogenase
– LIP6 – Secreted lipase, member of family of lipase genes expressed differentially in response to carbon source and during
infection
– PTP3 PTP3 Protein not essential for viability; similar to S. cerevisiae Ptp3p, which is a protein tyrosine phosphatase
– PTP1 PTP1 Ortholog(s) have protein tyrosine phosphatase activity
– APL5 APL5 Phosphorylated protein, not essential for viability; similar to S. cerevisiae Apl5p, which is a subunit of the AP-3 adaptor
complex involved in Golgi-to-vacuole transport
– YHB1 YHB1 Nitric oxide dioxygenase, acts in nitric oxide scavenging/detoxiﬁcation; role in virulence in mouse
+/ NUP85 NUP85 Ortholog(s) have role in mRNA export from nucleus, ribosomal large subunit export from nucleus, nuclear envelope
organization and Nup107–160 complex localization
– DOA4 DOA4 Protein similar to S. cerevisiae Doa4p, a ubiquitin hydrolase
+/ SSN8 SSN8 Protein similar to S. cerevisiae Ssn8p, a component of RNA polymerase II holoenzyme
+/ CaO19.4736 PHO8 Ortholog(s) have nucleotide phosphatase activity, alkaline phosphatase activity
Cell wall proteins
+/ CaO19.5412 ECM9 Ortholog(s) have role in fungal-type cell wall organization
– CDC10 CDC10 Septin, required for wild-type cell, hyphal, or chlamydospore morphology
+/ MNN9 MNN9 Protein of N-linked outer-chain mannan biosynthesis
Transcriptional factor
+/ ACE2 ACE2 Transcription factor involved in regulation of morphogenesis
– MNL1 YER130C Transcription factor that activates transcription of stress response genes via SLE (STRE-like) elements
+/ FKH2 FKH2 Forkhead transcription factor; morphogenesis regulator
+/ GZF3 GZF3 Putative transcription factor; oxidative stress-induced via Cap1p
* The sensitivity to propolis was veriﬁed by comparing the growth of mutants with their respective wild type strains (CAI4, SC5314, BWP17 and DAY286). For this, we created
a legend with the signs + and , which indicate the degree of strains susceptibility. In YPD solid medium containing 1% propolis, wild type strains grown as +. The
Supplementary Table S1 shows the full dataset and the cell growth that corresponds to: +, +/, +/. +/.
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implants and this bioﬁlm formation can protect the fungus from
host defenses and reduce their susceptibility to antifungal agents
(for reviews, see Bonhomme and d’Enfert, 2013; Mayer et al.,
2013; and Ganguly and Mitchell, 2011). Harriott et al. (2010) have
shown that C. albicans 3153A can form bioﬁlms on the vaginal mu-
cosa in vivo and ex vivo, demonstrating typical bioﬁlm architecture
and the presence of an extracellular matrix (ECM) that co-localized
with the presence of the fungus. Thus, we determined if propolis
could affect the in vitro bioﬁlm formation by incubating C. albicans
bioﬁlm in the presence of either ethanol (control) or propolis and
evaluating the bioﬁlm metabolic activity via the XTT reduction as-
say, which directly correlates with the metabolic activity of the
bioﬁlm. There was a 40–45% reduction in metabolic activity when
the bioﬁlm was exposed to 0.25–1.25% propolis, respectively(Fig. 6C), indicating that propolis can decrease C. albicans bioﬁlm
formation in vitro.
The previously presented results were corroborated by the
histological analysis, which shows the control (without any treat-
ment) and propolis treated groups (G3 and E3) all after 10 days of
treatment (Fig. 7). The results showed that estradiol ministration
maintained the pseudo-estrus condition and the presence of infec-
tion. The histological analyses of these experiments corroborated
the fungal burden analysis. In the control without treatment, we
observed using HE staining, tissue lesion and especially the
presence of neutrophils inﬂux (Fig. 7A, a). In addition, an absence
of irritation or inﬂammation induced by G3 and E3 treatments,
while rare immune cells were detected (Fig. 7A, c and e). The
morphological aspects of the tissues displayed normal architecture
and thickness in the pseudo-estrus phase, with keratin deposition
Fig. 4. Propolis can inhibit C. albicans the transition from yeast-to-hyphal growth.
The ﬁlamentation of SC5314 strain was induced in RPMI1640 medium exposed, or
not, to different propolis concentrations. Cell viability was not decreased upon
propolis exposure as shown by a tenfold dilution drop-out assay (A). The inﬂuence
of propolis on ﬁlamentation was evaluated by analyzing at least 100 cells per
treatment on the microscope and the percentage ﬁlamentous cells was calculated
(B). Statistical analyses t test p < 0.01; different from the control; # different from
0.05%; and ## different from 0.1%.
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(Fig. 7A, d and f). Histological slices of vaginal mucosa, 10 days after
the interruption of the treatments, showed the presence of C. albi-
cans in the clotrimazole treatment group, similar to that observed
in the non-treated control group (Fig. 8A, b and d). In contrast, C.
albicans was not observed in all propolis formulations (Fig. 8B).Fig. 5. C. albicans cells exposed to propolis auto-ﬂuoresce. The ﬁlamentation of SC5314 st
with Mitotracker and DAPI, then visualized on a ﬂuorescent microscope. Bar: 10 m.Taken together, these results suggest that propolis can inhibit
the growth in vivo of a C. albicans hypervirulent strain in a candidi-
asis vulvovaginal model of infection to the same extent as
clotrimazole.4. Discussion
Although C. albicans is commonly associated with various types
of infections, such as vulvogaginal candidiasis, the development of
a universal therapeutic treatment for this disease remains a major
challenge, because of various problems associated with conven-
tional treatments such as toxicity, side effects, resistance and
recidivism. The use of natural products for the treatment of candi-
diasis has been gaining popularity both in practical use and
research. Recently, Kim et al. (2012) showed a quantitative and
qualitative analysis of the antifungal activity of allicin (an organic
compound, derived mainly from garlic) in C. albicans. A wide
variety of natural antifungal compounds have been discovered
(Abu et al., 2011; Lee and Chee, 2010; Alireza et al., 2009; Zhang
et al., 2006) and understanding the mode of action of these com-
pounds is extremely important for the development of an effective
antifungal therapy.
The health beneﬁts and also biological activities of propolis
have long been known. Propolis contains resinous substances col-
lected by honey bees, from various plants, thus forming a complex
of biologically active substances. Currently, propolis has received
the attention of clinicians and researchers due to its diverse phar-
macological activities and low toxicity (da Silva Frozza et al., 2012;
Agarwal et al., 2012; Bankova, 2009). Here, we evaluated the anti-
fungal activity of propolis against C. albicans. We observed that
propolis induced cell death in C. albicans and also inhibited all
three C. albicans morphogenetic types. Previous studies have
shown that various stimuli, including acetic acid, hydrogen perox-
ide, farnesol, lactoferrin, defensins, the antifungal agent amphoter-
icin B (Phillips et al. (2003), Lu et al., 2011; Shirtliff et al., 2009;
Nikawa et al., 1993; Vylkova et al., 2007; Al-Dhaheri and Douglas,
2010; Hao et al., 2013; Zhu et al., 2011) induce C. albicans cells
towards cell death-like apoptosis. Recently, Zhu et al. (2011)rain was induced in RPMI1640 medium, as described in Fig. 4. The cells were stained
Fig. 6. Propolis can reduce C. albicans burden in a vulvovaginal candidiasis mouse
model. (A) Fungal burden after 10 days propolis treatment and (B) after 10 days
following interruption of the propolis treatment. C = control; G2%, G3%, and E3%
(propolis formulations G2, G3 gels, and E3 emulsion with 2%, 3%, and 3% propolis
dry matter) and Clot (clotrimazole 10 mg/g). Indicates all the propolis treatments
were different from the control but statistically similar to the clotrimazole
treatment (p < 0.05, ANOVA one-way with Bonferroni post-test). (C) Inhibition of
C. albicans 3153A strain bioﬁlm formation by propolis. The results were the
average ± standard deviation of three repetitions (signiﬁcant difference, ANOVA
one-way – Bonferroni post-test, a = 0.05).
82 P.A. de Castro et al. / Fungal Genetics and Biology 60 (2013) 74–86elucidated to the mechanism behind farnesol-induced apoptosis in
C. albicans, suggesting the potential use of this redox-cycling agent
as an alternative antifungal agent. Hao et al. (2013) also showed
that caspofungin (an antifungal agent in the echinocandin class)
exerts activity against C. albicans by causing apoptosis and necro-
sis. However, until now, little was known about the effector mole-
cules that are associated with the onset of PCD in C. albicans.
Furthermore, propolis was observed to contain compounds that
confer ﬂuorescent properties to C. albicans cells. We proved that
the ﬂuorescent compounds from propolis, such as phenolics, weredistributed throughout the cytoplasm and concentrated in the
mitochondria. However, this ﬂuorescence was not observed for S.
cerevisiae cells treated with the same concentrations of propolis
(de Castro et al., 2011). This could be due to the fact that C. albicans
is more permeable than S. cerevisiae to the ﬂuorescent compounds
in propolis and/or other compounds present in C. albicans became
ﬂuorescent when they reacted with propolis. This propolis-induced
autoﬂuorescence did not allow us to perform caspase activity,
TUNEL and propidium iodide assays, since all these techniques
are dependent on ﬂuorophores (data not shown).
Cao et al. (2009) provided the ﬁrst evidence that caspase activ-
ity was involved in C. albicans oxidative stress-induced PCD. This
caspase activity was attributed to the C. albicans homologue of
the S. cerevisiae metacaspase YCA1. Our data demonstrated that
cell death induced by propolis was mediated via this metacaspase,
since the metacaspase mutant in C. albicans showed reduced sensi-
tivity to propolis. Moreover, our results indicated that the Ras
pathway was also involved in cell death induced by propolis. Ras
is a member of a highly conserved family of GTP binding proteins
that act as an important molecular switch in a variety of signaling
pathways that control cell growth and differentiation (Leberer
et al., 2001). The Ras pathway has been strongly linked to morpho-
genetic signals in certain fungi, and C. albicans ras1 regulates a di-
verse set of phenotypes critical for both commensal and
pathogenic lifestyles within the host (Piispanen et al., 2011) and
it is also linked to apoptosis signaling (Cao et al., 2009). Deletion
of ras1 in C. albicans is able to slow down or even prevent PCD,
as is the case with the S. cerevisiae ras2 strain (D’Souza and Heit-
man, 2001; Feng et al.,1999; Phillips et al., 2006).
The yeast-to-hyphal morphological transition in the opportu-
nistic pathogen C. albicans plays a critical role in the ability of this
fungus to colonize as a commensal symbiont and cause disease as a
pathogen (Zacchi et al., 2010; Mitchell, 1998; Gow et al., 2002). The
immune system is able to discriminate between yeast and hyphal
growth. This speciﬁc recognition of the C. albicans morphology, to-
gether with the detection of fungal burden and of the damage
caused by the invading hyphae, might be the key for the discrimi-
nation between host colonization and infection (Jacobsen et al.,
2012; Whiteway and Bachewich, 2007). Therefore, the inhibition
of the yeast-to-hyphal transition or the modulation of the immune
response associated with dimorphism presents a very attractive
option for the control of C. albicans infections. We observed that
C. albicans cdc35D and ras1Dmutants showed a reduction in prop-
olis-induced cell death compared with the wild-type, while tpk1D,
tpk2D and pde2Dmutants that showed greater sensitivity to prop-
olis. This fact conﬁrms the hypothesis that the disruption of
Ras-cAMP-PKA signaling partially inhibits the rate of entry into
apoptosis, but does not prevent it if the stimulus is strong enough,
for example, by the use of propolis. The Ras-cAMP-PKA signaling
pathway also plays an important role in the activation of C. albicans
yeast to hyphal transition. Leberer et al. (2001) have shown that C.
albicans Ras1 conveys signals to both the ﬁlament-inducing MAP
kinase signaling pathway and the cAMP signaling pathway in order
to promote C. albicans ﬁlamentous growth and virulence. Thus, Ras
signaling provides an important link between polarized morpho-
genesis and virulence in this human pathogen. The cAMP-activated
protein kinase A pathway plays a pivotal role in C. albicans
morphogenesis and infection biology (Biswas et al., 2007). The
screening of C. albicans deletion libraries showed several mutants
that correspond to genes involved in either the morphological
transitions or in the maintenance of a speciﬁc morphotype (HST7,
VPS34, PTP3, MNN9, SUV3, MDS3, ACE2, CDC10, FKH2, YHB1, PTP1,
GIN4) as more sensitive to propolis. This enrichment may be due
to the inherent bias of the gene knockout collection, which
contains a high proportion of genes required for morphogenesis.
Additionally, the kinases identiﬁed are central regulators of cell
Fig. 7. Histological slices of vaginal mucosa of mice 10 days of treatment. Negative control group without any treatment (a and b), presentation of G3 (c and d) and E3 (e and
f) treated groups (treatments applied every 12 h). Tissular irritation, inﬂammation and neutrophils inﬂux were seen (HE staining) in the control infected group (a). C. albicans
presence in this group was showed by GMS staining (b) demonstrating that vaginal candidiasis model was successfully implemented (40 magniﬁcation). Pictures of G3 and
E3 treatments demonstrated that propolis restored the lesions caused by Candida presence when compared to control group (a and b) and that these treatments do not show
the presence of Candida, corroborating the data shown in Fig. 6.
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defect in ﬁtness. We validated these results by showing that prop-
olis can inhibit the yeast-to-hyphal al transition.
The compounds present in the propolis that are inhibiting the
yeast-to-hyphal transition are yet to be discovered. However, far-
nesol and eugenol have already been identiﬁed in the Brazilian
red propolis (Righi et al., 2011). E-nerolidol has been identiﬁed in
the essential oil extracted from Baccharis dracunculifolia, the most
important plant source of the Brazilian green propolis (Parreira
et al., 2010; Johann et al., 2012), which has been shown to have hy-
phal-inhibiting activity (Shareck and Belhumeur, 2011). In C. albi-
cans dimorphism and bioﬁlm formation is affected by farnesol
(Langford et al., 2009), while Hall et al. (2011) recently showed that
farnesol directly inhibits adenylyl cyclase activity both in vitro and
in vivo. E-nerolidol and dodecanol induced a reduction in both C.
albicans and C. dubliniensis ﬁlamentation (Martins et al., 2007).
Eugenol induced a severe modiﬁcation in the C. albicans morpho-
genesis (Braga et al., 2007). Martins et al. (2012) have injected
intraperitoneally a cocktail with different concentrations of iso-
amyl alcohol, phenylethanol, nerolidol, and farnesol in a murine
model of hematogenously disseminated candidiasis. They demon-
strated this treatment increased survival and decreased organ fun-
gal burden when compared to the control mice. Thus, it is possiblethat the combination of these compounds and other unknown sub-
stances present in propolis are able to inhibit the yeast-to-hyphal
transition.
Finally, we have shown that both the propolis based gels (G2
and G3) and cream (E3) were partially able to control vulvovaginal
candidiasis in a mouse model. Our results strongly indicate that
propolis represents a promising alternative therapeutic with great
potential to control vulvovaginal candidiasis. Taken into consider-
ation the fact that propolis is a complex substance with several
possible antifungal active compounds, it may be more difﬁcult
for resistance to evolve in C. albicans, as it would require several
concomitant mutations. Moreover, it is possible to increase its
therapeutic value by combining propolis with other antifungal
agents, such as azoles or caspofungin and with possible different
delivery systems (pharmaceutical vehicles). Another promising as-
pect of this combined therapy is the fact that propolis inhibits the
yeast-to-hyphal transition which contributes to the overall viru-
lence of C. albicans and may even constitute a target for the devel-
opment of antifungal drugs. Indeed, the inhibition of C. albicans
morphogenesis has been suggested as a good target for drug devel-
opment and controlling C. albicans infections (Saville et al., 2006;
Shareck and Belhumeur, 2011). Actually, a large number of small
molecules such as farnesol, fatty acids, rapamycin, geldanamycin,
Fig. 8. Histological slices of mice vaginal mucosa 10 days after the interruption of the treatments, showing (A) infected control group (a and b) and Clotrimazole treated group
(c and d). Histological analyses demonstrated that C. albicans infection causes vaginal lesion with neutrophils inﬂux (a and c, HE staining). Also, the presence of C. albicans in
both groups was shown by GMS staining (b and d). Propolis treatments (B) demonstrated restored vaginal tissue in all groups: G2 (a), G3 (c) and E3 (e), since normal tissue
can be seen in all pictures with the absence of inﬂammation. The absence of C. albicans corroborated previous results seen in Fig. 7 (40 magniﬁcation).
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modulate the yeast-to-hyphal transition in C. albicans (for a revi-
sion, see Shareck and Belhumeur, 2011). Once more, this opens
the possibility to apply propolis in a combined therapy with these
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